0001209191-21-009464.txt : 20210210 0001209191-21-009464.hdr.sgml : 20210210 20210210201140 ACCESSION NUMBER: 0001209191-21-009464 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210208 FILED AS OF DATE: 20210210 DATE AS OF CHANGE: 20210210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: APPLE ROBERT F CENTRAL INDEX KEY: 0001054942 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32302 FILM NUMBER: 21616017 MAIL ADDRESS: STREET 1: C/O INKLINE PHARMACEUTICAL CO INC STREET 2: SENTRY PARK EAST 1720 WALTON ROAD CITY: BLUE BELL STATE: PA ZIP: 19422 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANTARES PHARMA, INC. CENTRAL INDEX KEY: 0001016169 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411350192 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 BUSINESS PHONE: 609-359-3020 MAIL ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20060120 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20020520 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/ DATE OF NAME CHANGE: 20010604 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-08 0 0001016169 ANTARES PHARMA, INC. ATRS 0001054942 APPLE ROBERT F C/O ANTARES PHARMA, INC. 100 PRINCETON SOUTH, SUITE 300 EWING NJ 08628 1 1 0 0 President & CEO Common Stock 2021-02-08 4 M 0 33574 2.62 A 2328729 D Common Stock 2021-02-08 4 S 0 33574 4.75 D 2295155 D Common Stock 2021-02-09 4 M 0 49129 2.62 A 2344284 D Common Stock 2021-02-09 4 S 0 49129 4.75 D 2295155 D Common Stock 2021-02-10 4 M 0 7278 2.62 A 2302433 D Common Stock 2021-02-10 4 S 0 7278 4.75 D 2295155 D Stock Option (right to buy) 2.62 2021-02-08 4 M 0 33574 0.00 D 2025-03-09 Common Stock 33574 0 D Stock Option (right to buy) 2.62 2021-02-09 4 M 0 49129 0.00 D 2025-03-09 Common Stock 49129 0 D Stock Option (right to buy) 2.62 2021-02-10 4 M 0 7278 0.00 D 2025-03-09 Common Stock 12797 0 D The stock option exercises and sales of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The options vested in equal quarterly installments over one year from the grant date of March 10, 2015. /s/Keith Muckenhirn as attorney-in-fact for Robert F. Apple 2021-02-10